SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-073718
Filing Date
2020-03-16
Accepted
2020-03-16 07:01:07
Documents
16
Period of Report
2020-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d900170d8k.htm   iXBRL 8-K 40931
2 EX-4.1 d900170dex41.htm EX-4.1 73122
3 EX-99.1 d900170dex991.htm EX-99.1 5150
4 EX-99.2 d900170dex992.htm EX-99.2 8880
8 GRAPHIC g900170g0316061312476.jpg GRAPHIC 2714
  Complete submission text file 0001193125-20-073718.txt   285612

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA zyme-20200316.xsd EX-101.SCH 2750
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20200316_lab.xml EX-101.LAB 18848
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20200316_pre.xml EX-101.PRE 11838
12 EXTRACTED XBRL INSTANCE DOCUMENT d900170d8k_htm.xml XML 3453
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 20715230
SIC: 2834 Pharmaceutical Preparations